108 Medical Ltd.

POWER SEARCH PRICING

SOLUTIONS

108 medical ltd. Company Information

Company Number

02520520

Next Accounts

Mar 2025

Directors

Anthony Chancellor Weale

Simon Marsh

View All

Shareholders

georgia alice louise gilmore

anna benedicta claire gilmore

View All

Group Structure

View All

Industry

Specialist medical practice activities

Registered Address

108 harley street, london, W1G 7ET

Website

http://thebreastclinic.co.uk

108 medical ltd. Estimated Valuation

£1.9m

Pomanda estimates the enterprise value of 108 MEDICAL LTD. at £1.9m based on an EBITDA of £502.4k and a 3.71x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

108 Medical Ltd. is a live company located in london, W1G 7ET with a Companies House number of 02520520. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in July 1990, it's largest shareholder is georgia alice louise gilmore with a 10.8% stake. 108 Medical Ltd. is a mature, small sized company, Pomanda has estimated its turnover at £1.9m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded 108 Medical Ltd. a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating4out of 5

4 Strong

4 Regular

3 Weak

Size

annual sales of £1.9m, make it larger than the average company (£376.1k)

Growth

3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (5.6%)

EXPORT

108 Medical Ltd.'s latest turnover from June 2023 is estimated at £1.9 million and the company has net assets of £539.4 thousand. According to their latest financial statements, 108 Medical Ltd. has 26 employees and maintains cash reserves of £556.8 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012	Jun 2011	Jun 2010
Turnover	1,913,869	1,839,436	1,634,096	2,263,167	2,714,719	3,500,447	4,321,165	5,441,027	12,196,987	9,171,127	6,486,027	5,993,399	6,584,950	8,244,992
Other Income Or Grants
Cost Of Sales	853,900	772,269	715,586	800,132	844,119	1,062,389	1,057,573	1,391,514	3,236,800	2,246,134	1,372,939	1,567,459	2,015,919	2,499,739
Gross Profit	1,059,968	1,067,167	918,509	1,463,035	1,870,600	2,438,059	3,263,592	4,049,513	8,960,188	6,924,993	5,113,089	4,425,940	4,569,031	5,745,253
Admin Expenses	696,027	534,281	969,292	1,829,194	2,129,493	2,516,996	3,307,799	4,052,889	8,878,904	6,721,429	4,927,873	4,327,105	4,349,413	5,690,154
Operating Profit	363,941	532,886	-50,783	-366,159	-258,893	-78,937	-44,207	-3,376	81,284	203,564	185,216	98,835	219,618	55,099
Interest Payable	17,947	10,344	11,895	5,948
Interest Receivable	25,233	4,888	303	167	1,054	1,150	612	1,105	871	1,168	1,112	767	662	238
Pre-Tax Profit	371,227	527,430	-62,375	-371,940	-257,839	-77,787	-43,595	-2,271	82,155	204,732	186,329	99,603	220,280	55,336
Tax	-92,807	-100,212							-16,431	-42,994	-42,856	-23,905	-57,273	-15,494
Profit After Tax	278,420	427,218	-62,375	-371,940	-257,839	-77,787	-43,595	-2,271	65,724	161,738	143,473	75,698	163,007	39,842
Dividends Paid
Retained Profit	278,420	427,218	-62,375	-371,940	-257,839	-77,787	-43,595	-2,271	65,724	161,738	143,473	75,698	163,007	39,842
Employee Costs	790,563	677,968	696,318	699,221	827,223	932,016	851,016	1,017,720	6,042,930	4,783,766	3,938,293	3,482,641	3,963,597	4,425,150
Number Of Employees	26	25	26	28	31	36	36	35	204	158	136	122	149	188
EBITDA*	502,371	586,946	-5,003	-314,191	-153,411	49,685	74,691	144,076	81,284	325,004	293,050	176,028	280,412	147,793

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012	Jun 2011	Jun 2010
Tangible Assets	414,599	171,389	162,853	169,990	183,302	258,773	279,861	349,690	491,831	606,456	225,168	285,084	254,637	304,714
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	414,599	171,389	162,853	169,990	183,302	258,773	279,861	349,690	491,831	606,456	225,168	285,084	254,637	304,714
Stock & work in progress
Trade Debtors	196,277	178,858	144,279	247,833	407,498	591,217	737,994	861,455	1,113,869	908,770	654,084	520,376	597,088	550,844
Group Debtors										9,543
Misc Debtors	342,029	202,962	181,116	182,267	234,997	210,911	196,734	161,394
Cash	556,810	452,496	329,550	276,196	57,590	223,549	236,384	253,094	189,003	159,395	307,755	137,212	169,685	95,038
misc current assets
total current assets	1,095,116	834,316	654,945	706,296	700,085	1,025,677	1,171,112	1,275,943	1,302,872	1,077,708	961,839	657,588	766,773	645,882
total assets	1,509,715	1,005,705	817,798	876,286	883,387	1,284,450	1,450,973	1,625,633	1,794,703	1,684,164	1,187,007	942,672	1,021,410	950,596
Bank overdraft
Bank loan	18,450	22,591	39,000
Trade Creditors	401,639	397,659	451,090	367,082	439,056	549,481	537,040	587,253	898,824	746,039	588,615	493,881	718,461	813,005
Group/Directors Accounts										1,050
other short term finances
hp & lease commitments	58,000	12,615	19,100	24,762	24,096	52,491	88,727	80,453
other current liabilities	229,333	242,529	305,871	361,230	111,369	67,133	135,036	161,157
total current liabilities	707,422	675,394	815,061	753,074	574,521	669,105	760,803	828,863	898,824	747,089	588,615	493,881	718,461	813,005
loans	217,500	67,774	156,000	195,000
hp & lease commitments			12,962	32,062	40,776	81,278	76,357	127,260
Accruals and Deferred Income
other liabilities									207,802	302,464	63,893	70,144		97,649
provisions	45,380	1,544				8,138	10,097	22,199	38,495	50,753	12,379
total long term liabilities	262,880	69,318	168,962	227,062	40,776	89,416	86,454	149,459	246,297	353,217	76,272	70,144		97,649
total liabilities	970,302	744,712	984,023	980,136	615,297	758,521	847,257	978,322	1,145,121	1,100,306	664,887	564,025	718,461	910,654
net assets	539,413	260,993	-166,225	-103,850	268,090	525,929	603,716	647,311	649,582	583,858	522,120	378,647	302,949	39,942
total shareholders funds	539,413	260,993	-166,225	-103,850	268,090	525,929	603,716	647,311	649,582	583,858	522,120	378,647	302,949	39,942

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013	Jun 2012	Jun 2011	Jun 2010
Operating Activities
Operating Profit	363,941	532,886	-50,783	-366,159	-258,893	-78,937	-44,207	-3,376	81,284	203,564	185,216	98,835	219,618	55,099
Depreciation	138,430	54,060	45,780	51,968	105,482	128,622	118,898	147,452		121,440	107,834	77,193	60,794	92,694
Amortisation
Tax	-92,807	-100,212							-16,431	-42,994	-42,856	-23,905	-57,273	-15,494
Stock
Debtors	156,486	56,425	-104,705	-212,395	-159,633	-132,600	-88,121	-91,020	195,556	264,229	133,708	-76,712	46,244	550,844
Creditors	3,980	-53,431	84,008	-71,974	-110,425	12,441	-50,213	-311,571	152,785	157,424	94,734	-224,580	-94,544	813,005
Accruals and Deferred Income	-13,196	-63,342	-55,359	249,861	44,236	-67,903	-26,121	161,157
Deferred Taxes & Provisions	43,836	1,544			-8,138	-1,959	-12,102	-16,296	-12,258	38,374	12,379
Cash flow from operations	287,698	315,080	128,351	76,091	-68,105	124,864	74,376	68,386	9,824	213,579	223,599	4,255	82,351	394,460
Investing Activities
capital expenditure	-381,640	-62,596	-38,643	-38,656	-30,011	-107,534	-49,069	-5,311	114,625	-502,728	-47,918	-107,640	-10,717	-397,408
Change in Investments
cash flow from investments	-381,640	-62,596	-38,643	-38,656	-30,011	-107,534	-49,069	-5,311	114,625	-502,728	-47,918	-107,640	-10,717	-397,408
Financing Activities
Bank loans	-4,141	-16,409	39,000
Group/Directors Accounts									-1,050	1,050
Other Short Term Loans
Long term loans	149,726	-88,226	-39,000	195,000
Hire Purchase and Lease Commitments	45,385	-19,447	-24,762	-8,048	-68,897	-31,315	-42,629	207,713
other long term liabilities								-207,802	-94,662	238,571	-6,251	70,144	-97,649	97,649
share issue										-100,000			100,000	100
interest	7,286	-5,456	-11,592	-5,781	1,054	1,150	612	1,105	871	1,168	1,112	767	662	238
cash flow from financing	198,256	-129,538	-36,354	181,171	-67,843	-30,165	-42,017	1,016	-94,841	140,789	-5,139	70,911	3,013	97,987
cash and cash equivalents
cash	104,314	122,946	53,354	218,606	-165,959	-12,835	-16,710	64,091	29,608	-148,360	170,543	-32,473	74,647	95,038
overdraft
change in cash	104,314	122,946	53,354	218,606	-165,959	-12,835	-16,710	64,091	29,608	-148,360	170,543	-32,473	74,647	95,038

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for 108 medical ltd.. Get real-time insights into 108 medical ltd.'s credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for 108 medical ltd. by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in W1G area or any other competitors across 12 key performance metrics.

108 MEDICAL LTD. group structure

108 Medical Ltd. has no subsidiary companies.

Ultimate parent company

108 MEDICAL LTD.

02520520

108 MEDICAL LTD. Shareholders

georgia alice louise gilmore	10.8%
anna benedicta claire gilmore	10.8%
hugh inigo jeremy gilmore	10.8%
octavia phoebe hannah gilmore	10.8%
quentin roderick zebedee gilmore	10.8%
chiara novena jane gilmore	10.8%
deborah emma frances gilmore	10.8%
natasha olivia polly gilmore	10.8%
katherine laura matilda gilmore	10.8%
anthony david chancellor-weale	1%

108 Medical Ltd. currently has 4 directors. The longest serving directors include Mr Anthony Chancellor Weale (Jul 1991) and Mr Simon Marsh (Nov 2011).

officer	country	age	start	end	role
Mr Anthony Chancellor Weale		82 years	Jul 1991	-	Director
Mr Simon Marsh	England	62 years	Nov 2011	-	Director
Dr Charles Record	England	60 years	Nov 2016	-	Director
Ms Clair Linnane	England	51 years	Mar 2021	-	Director

P&L

June 2023

turnover

1.9m

+4%

operating profit

363.9k

gross margin

55.4%

-4.54%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2023

net assets

539.4k

+1.07%

total assets

1.5m

+0.5%

cash

556.8k

+0.23%

net assets

Total assets minus all liabilities

Similar Companies

international limb lengthening clinic ltd

european scanning centre (harley street) limited

london craniofacial unit limited

3.5

angus mcindoe limited

4.5

mr frank cross limited

company number

02520520

Type

Private limited with Share Capital

industry

86220 - Specialist medical practice activities

incorporation date

July 1990

ultimate parent company

None

previous names

the london breast clinic ltd (January 2010)

the breast clinic limited (December 1997)

address

108 harley street, london, W1G 7ET

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to 108 medical ltd.. Currently there are 1 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for 108 MEDICAL LTD.. This can take several minutes, an email will notify you when this has completed.

108 medical ltd. Company Information

108 medical ltd. Estimated Valuation

108 medical ltd. Estimated Valuation

108 medical ltd. Estimated Valuation

108 Medical Ltd. Overview

108 Medical Ltd. Health Check

108 MEDICAL LTD. financials

108 medical ltd. Credit Report and Business Information

108 Medical Ltd. Competitor Analysis

108 medical ltd. Ownership

108 medical ltd. directors

108 medical ltd. company details

108 medical ltd. Charges & Mortgages

108 medical ltd. Capital Raised & Share Issues BETA

108 medical ltd. Companies House Filings - See Documents